Visvin 30mg Injection

Visvin 30mg Injection contains the active substance decitabine, an antineoplastic drug belonging to the class of DNA methylation inhibitors. It is indicated for the treatment of myelodysplastic syndrome, a group of conditions characterised by the bone marrow producing misshapen blood cells and an insufficient quantity of healthy blood cells. It is also used to treat acute myeloid leukaemia (AML), a type of cancer. The mechanism of action involves inhibiting the growth of cancer cells.

Do not use this injection if you have a known allergy to decitabine or any other ingredient in this medicine. Inform your physician prior to treatment if you have an active infection, decreased blood cell count, liver disease, kidney disorder, or cardiac disorder. This medicine is not recommended for patients below 18 years of age.

This medicine can cause a serious immune reaction known as differentiation syndrome. Contact your physician immediately if you experience symptoms including sudden difficulty in breathing, cough, fever, or body swelling.

Visvin 30mg Injection is contraindicated in pregnant and breastfeeding women. Inform your physician if you are pregnant, planning pregnancy, or breastfeeding. Effective contraception must be used throughout treatment to prevent pregnancy.

Common adverse reactions include decreased white blood cell count, decreased red blood cell count, decreased platelet count, and elevated body temperature.

Visvin 30mg Injection is used in the treatment of the following: Myelodysplastic syndromes (MDS) Acute myeloid leukemia (AML)

Visvin 30mg Injection promotes hypomethylation of DNA and cellular differentiation or cell death after phosphorylation, direct incorporation into DNA, and inhibition of DNA methyltransferase. It works by helping the bone marrow produce normal blood cells and by killing abnormal cells in the bone marrow.

It will be given to you by a doctor or nurse in a hospital or clinic setting trained in cancer chemotherapy. It is given as an intravenous infusion drip (into your vein). This will take one hour. Do not self-administer the injection. Your doctor will decide the dose and duration of the treatment based on your disease severity, body weight, and other factors.

Side effects are unwanted symptoms caused by medicines. Even though all drugs cause side effects, not everyone gets them. Common side effects of Visvin 30mg Injection are: Swelling in the face, hands, and feet Swelling and pain in the skin Discoloration of the skin Increased blood sugar levels Decreased albumin levels Abdominal pain, constipation Decrease in appetite Diarrhea, indigestion Nausea, vomiting Insomnia, dizziness Pain in limbs Serious side effects of Visvin 30mg Injection are: Heart problems Anemia Infection Bleeding Fluid in the lungs Pneumonia

Male patient with a female partner of reproductive potential to use effective contraception during the therapy and for 3 months after the last dose. Report symptoms of infection, anaemia, or bleeding immediately to your doctor. Do not breastfeed during the treatment and for 1 week after the last dose. Visvin 30mg Injection may cause infertility in both men and women. Inform your doctor if you are planning for pregnancy before initiating the treatment. Visvin 30mg Injection may make you bleed, bruise, or get infections more easily. Take precautions to prevent illness and injury. Wash your hands often. Your doctor may advise you to take certain tests to check for the effectiveness of the therapy.